Ito M, Amari M, Sato A, Hikichi M, et al. Impact of extended endocrine therapy for patients with risk factors for late recurrence in estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer after 5 years of endocrine therapy. Breast Cancer Res Treat 2024 Oct 17. doi: 10.1007/s10549-024-07509.
PMID: 39417907